Home Companies Okami Medical COMPANY
FDA-cleared device company
Location: Aliso Viejo, CA · source · Oct 15, 2026
Profile checked Oct 10, 2026
At a glance HQ Aliso Viejo, CA source Stage FDA-cleared device company Funding and NIH signals SEC Form D raise Raised $28.94M (Form D filed Dec 1, 2025). SEC Form D 0001675564-25-000002 (Dec 1, 2025)Evidence (1 event) Dec 1, 2025 · SEC Form D 0001675564-25-000002 Name of Issuer: Okami Medical, Inc.; CIK: 1675564; Address: Aliso Viejo, CA; Submission type: D; Filing date: 2025-12-01; Industry Group: Other Technology; Date of First Sale: 2025-11-18; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 46735000; Total Amount Sold: 28936718; Federal exemptions: 06b Job counts as of Oct 18, 2026. All funding and NIH signals
Timeline Apr 10, 2026 FDA FDA 510(k) clearance: LOBO Vascular Occlusion System — K260508, Apr 10, 2026. Applicant at approval: Okami Medical, Inc. source ↗ Dec 20, 2024 FDA FDA 510(k) clearance: SENDERO MAX Delivery Catheter — K242644, Dec 20, 2024. Applicant at approval: Okami Medical, Inc. source ↗ FDA records (last 2 years) Apr 10, 2026 FDA 510(k) clearance: LOBO Vascular Occlusion System — K260508, Apr 10, 2026. Applicant at approval: Okami Medical, Inc. source ↗ Dec 20, 2024 FDA 510(k) clearance: SENDERO MAX Delivery Catheter — K242644, Dec 20, 2024. Applicant at approval: Okami Medical, Inc. source ↗ Connect See your connections at Okami Medical on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-12
